We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Cancer Conference Poster Prize Winner
Product News

Cancer Conference Poster Prize Winner

Cancer Conference Poster Prize Winner
Product News

Cancer Conference Poster Prize Winner


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Cancer Conference Poster Prize Winner"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

AMSBIO, regular sponsor of the annual Beatson International Cancer Conference has announced that the winner of the AMSBIO-Trevigen prize for the best poster was Katarzyna Grzes - a PhD researcher specializing in Cell Signaling and Immunology at the University of Dundee (Scotland, UK).

Miss Grzes was named as winner of the Poster Prize for the best presented and most interesting poster for her work entitled 'Metabolic regulation in PTEN null T lymphoma / leukemia'.

As one of Cancer Research UK’s core-funded institutes - the Beatson Institute (www.beatson.gla.ac.uk/) carries out a program of world-class science directed at understanding key aspects of cancer cell behaviour, and try to translate these discoveries into new therapies and diagnostic/prognostic tools to help cancer patients.

The Institute benefits from close interactions with the University of Glasgow, including strong links with the University’s Institute of Cancer Sciences.

AMSBIO is a rapidly growing company focused on the supply and development of products and technology for cancer research with emphasize on apoptosis, DNA damage and repair, and cancer cell function and behavior.

AMSBIO supplies focused research products for cancer research that allow researchers to study cancer cell function and behavior including in angiogenesis, cell invasion and PARP and PARG research.

Together with specifically designing assays for lead compound and genotoxic screening based on DNA damage and repair and cancer cell behavior, AMSBIO is establishing itself as a leading international provider of cancer research tools and services.

Advertisement